Home Casteddu.com	FAQ My Amedeo About	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Hepatitis

Free Subscription Articles published in Vaccine Retrieve available abstracts of 91 articles: HTML format

Single Articles

June 2009
1. BRAUN LJ , Jezek J, Peterson S, Tyagi A, et al
   Characterization of a thermostable hepatitis B vaccine formulation.
   Vaccine. 2009.
   PubMed     Related articles    Abstract available
   
   
   
2. DANIELSSON N , Fakakovikaetau T, Szegedi E
   Improved immunization practices reduce childhood hepatitis B infection in Tonga.
   Vaccine. 2009.
   PubMed     Related articles    Abstract available
   
   
   
3. ASTURIAS EJ , Mayorga C, Caffaro C, Ramirez P, et al
   Differences in the immune response to hepatitis B and Haemophilus influenzae type b vaccines in Guatemalan infants by ethnic group and nutritional status.
   Vaccine. 2009;27:3650-4.
   PubMed     Related articles    Abstract available
   
   
   
4. VAN HOUDT R , Koedijk FD, Bruisten SM, Coul EL, et al
   Hepatitis B vaccination targeted at behavioural risk groups in the Netherlands: Does it work?
   Vaccine. 2009;27:3530-5.
   PubMed     Related articles    Abstract available
   
   
   May 2009
5. KALTENBOCK A , Dubischar-Kastner K, Eder G, Jilg W, et al
   Safety and immunogenicity of concomitant vaccination with the cell-culture based Japanese encephalitis vaccine IC51 and the hepatitis A vaccine HAVRIX((R))1440 in healthy subjects: A single-blind, randomized, controlled Phase 3 study.
   Vaccine. 2009.
   PubMed     Related articles    Abstract available
   
   
   
6. EGAN PM , Belfast MT, Gimenez JA, Sitrin RD, et al
   Relationship between tightness of binding and immunogenicity in an aluminum-containing adjuvant-adsorbed hepatitis B vaccine.
   Vaccine. 2009;27:3175-80.
   PubMed     Related articles    Abstract available
   
   
   
7. KLADE CS , Kubitschke A, Stauber RE, Meyer MF, et al
   Hepatitis C virus-specific T cell responses against conserved regions in recovered patients.
   Vaccine. 2009;27:3099-108.
   PubMed     Related articles    Abstract available
   
   
   
8. VORSTERS A , Van Herck K, Van Damme P
   The clock is running, ...
   Vaccine. 2009;27:2905-6.
   PubMed     Related articles   
   
   
   
9. LUQUERO FJ , Vallejo F, Fuente LD, Toro C, et al
   The role of injection versus socioeconomic factors in hepatitis A virus infection among young heroin users: Implications for vaccination policies.
   Vaccine. 2009;27:2674-2679.
   PubMed     Related articles    Abstract available
   
   
   
10. LANDRUM ML , Hullsiek KH, Ganesan A, Weintrob AC, et al
    Hepatitis B vaccine responses in a large U.S. military cohort of HIV-infected individuals: Another benefit of HAART in those with preserved CD4 count.
    Vaccine. 2009.
    PubMed     Related articles    Abstract available
    
    
    April 2009
11. ZUBKOVA I , Choi YH, Chang E, Pirollo K, et al
    T-cell vaccines that elicit effective immune responses against HCV in chimpanzees may create greater immune pressure for viral mutation.
    Vaccine. 2009;27:2594-602.
    PubMed     Related articles    Abstract available
    
    
    
12. SAINI V , Sahoo MK, Murthy PK, Kohli D, et al
    Polymeric lamellar substrate particles as carrier adjuvant for recombinant hepatitis B surface antigen vaccine.
    Vaccine. 2009;27:2372-8.
    PubMed     Related articles    Abstract available
    
    
    March 2009
13. DENG Y , Zhang K, Tan W, Wang Y, et al
    A recombinant DNA and vaccinia virus prime-boost regimen induces potent long-term T-cell responses to HCV in BALB/c mice.
    Vaccine. 2009;27:2085-8.
    PubMed     Related articles    Abstract available
    
    
    
14. HU Y , Zhou YH
    Concerns on Bacille Calmette-Guerin vaccination in infants born to mothers with hepatitis B virus infection.
    Vaccine. 2009;27:1987-8.
    PubMed     Related articles   
    
    
    February 2009
15. ROMANO L , Paladini S, Tagliacarne C, Zappa A, et al
    The changing face of the epidemiology of type A, B, and D viral hepatitis in Italy, following the implementation of vaccination.
    Vaccine. 2009.
    PubMed     Related articles    Abstract available
    
    
    
16. RAPICETTA M , D'Ugo E, Argentini C, Catone S, et al
    New perspectives for hepatitis B vaccines and immunization.
    Vaccine. 2009.
    PubMed     Related articles    Abstract available
    
    
    
17. SANGARE L , Manhart L, Zehrung D, Wang CC, et al
    Intradermal hepatitis B vaccination: A systematic review and meta-analysis.
    Vaccine. 2009.
    PubMed     Related articles    Abstract available
    
    
    January 2009
18. KAO JT , Wang JH, Hung CH, Yen YH, et al
    Long-term efficacy of plasma-derived and recombinant hepatitis B vaccines in a rural township of Central Taiwan.
    Vaccine. 2009.
    PubMed     Related articles    Abstract available
    
    
    
19. ZHANG J , Liu CB, Li RC, Li YM, et al
    Randomized-controlled phase II clinical trial of a bacterially expressed recombinant hepatitis E vaccine.
    Vaccine. 2009.
    PubMed     Related articles    Abstract available
    
    
    
20. LU PJ , Euler GL, Hennessey KA, Weinbaum CM, et al
    Hepatitis A vaccination coverage among adults aged 18-49 years in the United States.
    Vaccine. 2009.
    PubMed     Related articles    Abstract available
    
    
    
21. GRIFFITHS UK , Korczak VS, Ayalew D, Yigzaw A, et al
    Incremental system costs of introducing combined DTwP-hepatitis B-Hib vaccine into national immunization services in Ethiopia.
    Vaccine. 2009.
    PubMed     Related articles    Abstract available
    
    
    
22. GIRAUDON I , Permalloo N, Nixon G, Charlett A, et al
    Factors associated with incomplete vaccination of babies at risk of perinatal hepatitis B transmission: A London study in 2006.
    Vaccine. 2009.
    PubMed     Related articles    Abstract available
    
    
    
23. HALPERIN SA , Tapiero B, Diaz-Mitoma F, Law BJ, et al
    Safety and immunogenicity of a hexavalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine at 2, 3, 4, and 12-14 months of age.
    Vaccine. 2009.
    PubMed     Related articles    Abstract available
    
    
    December 2008
24. KRETZSCHMAR M , Mangen MJ, van de Laar M, de Wit A, et al
    Model based analysis of hepatitis B vaccination strategies in the Netherlands.
    Vaccine. 2008.
    PubMed     Related articles    Abstract available
    
    
    
25. ARANKALLE VA , Lole KS, Deshmukh TM, Srivastava S, et al
    Challenge studies in Rhesus monkeys immunized with candidate hepatitis E vaccines: DNA, DNA-prime-protein-boost and DNA-protein encapsulated in liposomes.
    Vaccine. 2008.
    PubMed     Related articles    Abstract available
    
    
    
26. HANSEN B , Belfast M, Soung G, Song L, et al
    Effect of the strength of adsorption of hepatitis B surface antigen to aluminum hydroxide adjuvant on the immune response.
    Vaccine. 2008.
    PubMed     Related articles    Abstract available
    
    
    November 2008
27. XIE Y , Sun HX, Li D
    Platycodin D is a potent adjuvant of specific cellular and humoral immune responses against recombinant hepatitis B antigen.
    Vaccine. 2008.
    PubMed     Related articles    Abstract available
    
    
    
28. GREENGOLD B , Nyamathi A, Kominski G, Wiley D, et al
    Cost-effectiveness analysis of behavioral interventions to improve vaccination compliance in homeless adults.
    Vaccine. 2008.
    PubMed     Related articles    Abstract available
    
    
    
29. MONATH TP , Frey SE
    Possible autoimmune reactions following smallpox vaccination: The biologic false positive test for syphilis.
    Vaccine. 2008.
    PubMed     Related articles    Abstract available
    
    
    
30. GARNER-SPITZER E , Kundi M, Rendi-Wagner P, Winkler B, et al
    Correlation between humoral and cellular immune responses and the expression of the hepatitis A receptor HAVcr-1 on T cells after hepatitis A re-vaccination in high and low-responder vaccinees.
    Vaccine. 2008.
    PubMed     Related articles    Abstract available
    
    
    
31. CRUCIANI M , Mengoli C, Serpelloni G, Lanza A, et al
    Serologic response to hepatitis B vaccine with high dose and increasing number of injections in HIV infected adult patients.
    Vaccine. 2008.
    PubMed     Related articles    Abstract available
    
    
    October 2008
32. LIU FY , Guo RM, Zheng L, Lu YM, et al
    Safety evaluation of a canine hepatitis DNA vaccine.
    Vaccine. 2008.
    PubMed     Related articles    Abstract available
    
    
    
33. SIMANI OE , Leroux-Roels G, Francois G, Burnett RJ, et al
    Reduced detection and levels of protective antibodies to hepatitis B vaccine in under 2-year-old HIV positive South African children at a paediatric outpatient clinic.
    Vaccine. 2008.
    PubMed     Related articles    Abstract available
    
    
    
34. POLAT A , Akca H, Dagdeviren E
    Severe thrombocytopenia after hepatitis B vaccine in an infant from Turkey.
    Vaccine. 2008.
    PubMed     Related articles    Abstract available
    
    
    
35. ZANETTI AR , Van Damme P, Shouval D
    The global impact of vaccination against hepatitis B: A historical overview.
    Vaccine. 2008.
    PubMed     Related articles    Abstract available
    
    
    September 2008
36. RENOUX V , Fleury MJ, Bousarghin L, Gaitan J, et al
    Induction of antibody response against hepatitis E virus (HEV) with recombinant human papillomavirus pseudoviruses expressing truncated HEV capsid proteins in mice.
    Vaccine. 2008.
    PubMed     Related articles    Abstract available
    
    
    
37. BUT DY , Lai CL, Lim WL, Fung J, et al
    Twenty-two years follow-up of a prospective randomized trial of hepatitis B vaccines without booster dose in children: Final report.
    Vaccine. 2008.
    PubMed     Related articles    Abstract available
    
    
    
38. ARYA SC , Agarwal N, Gupta S
    Apropos "Hepatitis A in Jerusalem-The exception that proves the rule?"
    Vaccine. 2008.
    PubMed     Related articles   
    
    
    
39. HU Y , Wu Q, Xu B, Zhou Z, et al
    Influence of maternal antibody against hepatitis B surface antigen on active immune response to hepatitis B vaccine in infants.
    Vaccine. 2008.
    PubMed     Related articles    Abstract available
    
    
    
40. OVIEDO M , Pilar Munoz M, Dominguez A, Borras E, et al
    A statistical model to estimate the impact of a hepatitis A vaccination programme.
    Vaccine. 2008.
    PubMed     Related articles    Abstract available
    
    
    
41. NYSTROM J , Cardell K, Bjornsdottir TB, Fryden A, et al
    Improved cell mediated immune responses after successful re-vaccination of non-responders to the hepatitis B virus surface antigen (HBsAg) vaccine using the combined hepatitis A and B vaccine.
    Vaccine. 2008.
    PubMed     Related articles    Abstract available
    
    
    
42. YIN Y , Zhang J, Dong D, Liu S, et al
    Chimeric hepatitis B virus core particles carrying an epitope of anthrax protective antigen induce protective immunity against Bacillus anthracis.
    Vaccine. 2008.
    PubMed     Related articles    Abstract available
    
    
    August 2008
43. FITZSIMONS DW
    Prevention and control of viral hepatitis: The role and impact of patient and advocacy groups in and outside Europe.
    Vaccine. 2008.
    PubMed     Related articles    Abstract available
    
    
    
44. REIN DB , Weinbaum CM
    The cost-effectiveness of using hepatitis A/B combined vaccine versus hepatitis B vaccine alone for high-risk heterosexuals.
    Vaccine. 2008.
    PubMed     Related articles    Abstract available
    
    
    
45. LANG KA , Yan J, Draghia-Akli R, Kahn A, et al
    Strong HCV NS3- and NS4A-specific cellular immune responses induced in mice and Rhesus Macaques by a novel HCV genotype 1a/1b consensus DNA vaccine.
    Vaccine. 2008.
    PubMed     Related articles    Abstract available
    
    
    
46. STEIN-ZAMIR C , Shoob H, Nubani N, Zentner G, et al
    Hepatitis a in Jerusalem-The exception that proves the rule?
    Vaccine. 2008.
    PubMed     Related articles   
    
    
    
47. LORENZO G , Martin-Folgar R, Rodriguez F, Brun A, et al
    Priming with DNA plasmids encoding the nucleocapsid protein and glycoprotein precursors from Rift Valley fever virus accelerates the immune responses induced by an attenuated vaccine in sheep.
    Vaccine. 2008.
    PubMed     Related articles    Abstract available
    
    
    July 2008
48. QIU Q , Wang RY, Jiao X, Jin B, et al
    Induction of multispecific Th-1 type immune response against HCV in mice by protein immunization using CpG and Montanide ISA 720 as adjuvants.
    Vaccine. 2008.
    PubMed     Related articles    Abstract available
    
    
    June 2008
49. PRYMULA R , Chlibek R, Splino M, Kaliskova E, et al
    Safety of the 11-valent pneumococcal vaccine conjugated to non-typeable Haemophilus influenzae-derived protein D in the first 2 years of life and immunogenicity of the co-administered hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inac
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
50. ZHUANG GH , Pan XJ, Wang XL
    A cost-effectiveness analysis of universal childhood hepatitis A vaccination in China.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
51. SEO HS , Park JS, Han KY, Bae KD, et al
    Analysis and characterization of hepatitis B vaccine particles synthesized from Hansenula polymorpha.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
52. FYTILI P , Dalekos GN, Schlaphoff V, Suneetha PV, et al
    Cross-genotype-reactivity of the immunodominant HCV CD8 T-cell epitope NS3-1073.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
53. PARK SH , Lee SR, Hyun BH, Kim BM, et al
    Codelivery of PEG-IFN-alpha inhibits HCV DNA vaccine-induced T cell responses but not humoral responses in African green monkeys.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
54. LUXEMBOURG A , Hannaman D, Wills K, Bernard R, et al
    Immunogenicity in mice and rabbits of DNA vaccines expressing woodchuck hepatitis virus antigens.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    May 2008
55. DUTTA T , Garg M, Jain NK
    Poly(propyleneimine) dendrimer and dendrosome mediated genetic immunization against hepatitis B.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
56. LIN HH , Liao HW, Lin SK, Wang LY, et al
    HLA and response to booster hepatitis B vaccination in anti-HBs-seronegative adolescents who had received primary infantile vaccination.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    April 2008
57. SAADE F , Buronfosse T, Pradat P, Abdul F, et al
    Enhancement of neutralizing humoral response of DNA vaccine against duck hepatitis B virus envelope protein by co-delivery of cytokine genes.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
58. XING Y , Huang Z, Lin Y, Li J, et al
    The ability of Hepatitis B surface antigen DNA vaccine to elicit cell-mediated immune responses, but not antibody responses, was affected by the deglysosylation of S antigen.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
59. ROSIC I , Malicevic S, Medic S, Vlasich C, et al
    Immune response by athletes to hepatitis B vaccination.
    Vaccine. 2008;.
    PubMed     Related articles   
    
    
    
60. LIANG A , Cao S, Han L, Yao Y, et al
    Construction and evaluation of the eukaryotic expression plasmid encoding two copies of somatostatin genes fused with hepatitis B surface antigen gene S.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
61. CHUA BY , Eriksson EM, Brown LE, Zeng W, et al
    A self-adjuvanting lipopeptide-based vaccine candidate for the treatment of hepatitis C virus infection.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
62. MUTWIRI G , Benjamin P, Soita H, Babiuk LA, et al
    Co-administration of polyphosphazenes with CpG oligodeoxynucleotides strongly enhances immune responses in mice immunized with Hepatitis B virus surface antigen.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
63. MARTIN P , Simon B, Lone YC, Chatel L, et al
    A vector-based minigene vaccine approach results in strong induction of T-cell responses specific of hepatitis C virus.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
64. BATDELGER D , Dandii D, Jirathitikal V, Bourinbaiar AS, et al
    Open-label trial of therapeutic immunization with oral V-5 Immunitor (V5) vaccine in patients with chronic hepatitis C.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    March 2008
65. EKRA D , Herbinger KH, Konate S, Leblond A, et al
    A non-randomized vaccine effectiveness trial of accelerated infant hepatitis B immunization schedules with a first dose at birth or age 6 weeks in Cote d'Ivoire.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
66. AJELLI M , Iannelli M, Manfredi P, degli Atti ML, et al
    Basic mathematical models for the temporal dynamics of HAV in medium-endemicity Italian areas.
    Vaccine. 2008;26:1697-707.
    PubMed     Related articles    Abstract available
    
    
    
67. POHLSCHEIDT M , Langer U, Minuth T, Bodeker B, et al
    Development and optimisation of a procedure for the production of Parapoxvirus ovis by large-scale microcarrier cell culture in a non-animal, non-human and non-plant-derived medium.
    Vaccine. 2008;26:1552-65.
    PubMed     Related articles    Abstract available
    
    
    February 2008
68. SKRASTINA D , Bulavaite A, Sominskaya I, Kovalevska L, et al
    High immunogenicity of a hydrophilic component of the hepatitis B virus preS1 sequence exposed on the surface of three virus-like particle carriers.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
69. DOMINGUEZ A , Oviedo M, Carmona G, Batalla J, et al
    Impact and effectiveness of a mass hepatitis A vaccination programme of preadolescents seven years after introduction.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
70. DIAZ-MITOMA F , Law B, Subramanya A, Hoet B, et al
    Long-term antibody persistence induced by a combined hepatitis A and B vaccine in children and adolescents.
    Vaccine. 2008;26:1759-1763.
    PubMed     Related articles    Abstract available
    
    
    January 2008
71. MURAKAMI H , Van Cuong N, Huynh L, Hipgrave DB, et al
    Implementation of and costs associated with providing a birth-dose of hepatitis B vaccine in Viet Nam.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
72. KARABAY O , Temel A, Koker AG, Tokel M, et al
    Influence of circadian rhythm on the efficacy of the hepatitis B vaccination.
    Vaccine. 2008;.
    PubMed     Related articles   
    
    
    
73. VANDEPAPELIERE P , Horsmans Y, Moris P, Van Mechelen M, et al
    Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
74. JAFARZADEH A , Zarei S, Shokri F
    Low dose revaccination induces robust protective anti-HBs antibody response in the majority of healthy non-responder neonates.
    Vaccine. 2008;26:269-76.
    PubMed     Related articles    Abstract available
    
    
    
75. FERNANDES SJ , Slhessarenko N, Souto FJ
    Effects of vertical HIV infection on the persistence of anti-HBs after a schedule of three doses of recombinant hepatitis B vaccine.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    December 2007
76. KOTWAL GJ
    Genetic diversity-independent neutralization of pandemic viruses (e.g. HIV), potentially pandemic (e.g. H5N1 strain of influenza) and carcinogenic (e.g. HBV and HCV) viruses and possible agents of bioterrorism (variola) by enveloped virus neutralizing co
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
77. CARNIEL EF , Morcillo AM, Blotta MH, Da Silva MT, et al
    Immunogenicity and safety of combined intradermal recombinant Hepatitis B with BCG vaccines at birth.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
78. WHEELER CM , Bautista OM, Tomassini JE, Nelson M, et al
    Safety and immunogenicity of co-administered quadrivalent human papillomavirus (HPV)-6/11/16/18 L1 virus-like particle (VLP) and hepatitis B (HBV) vaccines.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    November 2007
79. SELNIKOVA O , Moisseeva A, Zadorozhnaja V, Dokachenko A, et al
    Hepatitis A vaccination effectiveness during an outbreak in the Ukraine.
    Vaccine. 2007;.
    PubMed     Related articles   
    
    
    
80. JIANG WP , Chen JT, Wang X, Wang YL, et al
    Immunogenicity and safety of three consecutive lots of a new preservative-free inactivated hepatitis A vaccine (Healive((R))): A double-blind, randomized and controlled trial.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
81. LORENT E , Bierau H, Engelborghs Y, Verheyden G, et al
    Structural characterisation of the hepatitis C envelope glycoprotein E1 ectodomain derived from a mammalian and a yeast expression system.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
82. SALLERAS L , Dominguez A, Bruguera M, Plans P, et al
    Declining prevalence of hepatitis B virus infection in Catalonia (Spain) 12 years after the introduction of universal vaccination.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
83. MOHLER-KUO M , Steffen R, Bopp M, Jacobs RJ, et al
    Prevalence of hepatitis A virus risk factors in a very low endemic country, Switzerland.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    October 2007
84. LIN CC , Chang CK, Huang YL, Tseng HF, et al
    Low seroprevalence of hepatitis B surface antibody among nursing students in Taiwan: An implication for boosting.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
85. VANDEPAPELIERE P , Lau GK, Leroux-Roels G, Horsmans Y, et al
    Therapeutic vaccination of chronic hepatitis B patients with virus suppression by antiviral therapy: A randomized, controlled study of co-administration of HBsAg/AS02 candidate vaccine and lamivudine.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
86. BAUCH CT , Anonychuk AM, Pham BZ, Gilca V, et al
    Cost-utility of universal hepatitis A vaccination in Canada.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
87. FITZSIMONS D , Vorsters A, Hoppenbrouwers K, Van Damme P, et al
    Prevention and control of viral hepatitis through adolescent health programmes in Europe.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
88. BORKAKOTY B , Mahanta J, Biswas D
    HBV vaccination in hyperendemic remote tribal areas in India.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    September 2007
89. SERRANO B , Bayas JM, Bruni L, Diez C, et al
    Solid organ transplantation and response to vaccination.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    August 2007
90. LIU CY , Chang NT, Chou P
    Seroprevalence of HBV in immigrant pregnant women and coverage of HBIG vaccine for neonates born to chronically infected immigrant mothers in Hsin-Chu County, Taiwan.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
91. GIDDING HF , Warlow M, Macintyre CR, Backhouse J, et al
    The impact of a new universal infant and school-based adolescent hepatitis B vaccination program in Australia.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: